Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 11,021 shares at $47.57 ($525K) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Open-market sale of $525k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.57 | 5,021 | $239K | 45.5% |
| 2 | $47.57 | 5,021 | $239K | 45.5% |
| 3 | $48.30 | 979 | $47K | 9.0% |
| Total | $47.63 avg | 11,021 | $525K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |